Partnerships & Mergers

During the congress, specialists from the Moscow-based center presented research on head and neck imaging, the use of AI-powered diagnostic algorithms, and strategies for improving the quality of medical imaging examinations.

The agreement establishes a formal gateway between Abu Dhabi and California, creating new opportunities for collaboration across research, innovation, investment, and commercialization.

Through the HELM Cluster, the emirate has brought together research institutions, advanced healthcare infrastructure, genomics programs, manufacturing capabilities, and distribution networks within a single ecosystem.

The collaboration follows the signing of a Memorandum of Understanding and forms part of Saudi Arabia’s broader efforts to enhance preventive healthcare and improve outcomes for people living with chronic diseases.

The agreement was formalized by Ali El Ghamrawy, Chairperson of the Egyptian Drug Authority, and James Peter Komie, Chairperson of the Pharmacy Board of Sierra Leone, in the presence of Sierra Leone’s Ambassador to Egypt, Sadiq Sillah.

The proposed centre will operate within Abu Dhabi’s Health, Endurance, Longevity, and Medicine (HELM) Cluster, a strategic life sciences platform that integrates research, healthcare delivery, investment, commercialization, and biomanufacturing.

Unlike conventional EHR systems that add AI as an extra feature, IntelliCare places artificial intelligence at the centre of the clinical workflow.

The partnership traces its roots to 2009, when Vestergaard rehabilitated Emusanda Health Centre in Lurambi and transformed it into a community facility providing primary healthcare, maternal services, paediatric care, and HIV treatment.

Under the agreement, Tanmeyah will provide tailored financing solutions for healthcare providers, particularly small and medium-sized facilities that often face constraints in investing in digital infrastructure.

This broader licence gives AviadoBio the flexibility to explore new development pathways and external collaborations while continuing to advance its central nervous system pipeline.